Literature DB >> 10604721

Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen.

H H Heidtmann1, D M Nettelbeck, A Mingels, R Jäger, H G Welker, R E Kontermann.   

Abstract

Angiostatin, a potent inhibitor of angiogenesis, tumour growth and metastasis, is a biologically active fragment of plasminogen, containing the kringle domains 1-4. It is generated from plasminogen by limited proteolysis. We show that prostate-specific antigen (PSA), a serine proteinase secreted by human prostate and human prostate cancer cells, is able to convert Lys-plasminogen to biologically active angiostatin-like fragments, containing kringles 1-4, by limited proteolysis of peptide bond Glu439-Ala440 in vitro. In an in vitro morphogenesis assay, the purified angiostatin-like fragments inhibited proliferation and tubular formation of human umbilical vein endothelial cells with the same efficacy as angiostatin. This finding might help to understand growth characteristics of prostate cancer, which usually has low microvessel density and slow proliferation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10604721      PMCID: PMC2362961          DOI: 10.1038/sj.bjc.6692167

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Semenogelin, the predominant protein in human semen. Primary structure and identification of closely related proteins in the male accessory sex glands and on the spermatozoa.

Authors:  H Lilja; P A Abrahamsson; A Lundwall
Journal:  J Biol Chem       Date:  1989-01-25       Impact factor: 5.157

2.  PAP and PSA in prostatic carcinoma cell lines and aspiration biopsies: relation to hormone sensitivity and to cytological grading.

Authors:  M Hasenson; B Lundh; R Stege; K Carlström; A Pousette
Journal:  Prostate       Date:  1989       Impact factor: 4.104

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Primary structure of the 'bait' region for proteinases in alpha 2-macroglobulin. Nature of the complex.

Authors:  L Sottrup-Jensen; P B Lønblad; T M Stepanik; T E Petersen; S Magnusson; H Jörnvall
Journal:  FEBS Lett       Date:  1981-05-18       Impact factor: 4.124

5.  Carbohydrate of the human plasminogen variants. II. Structure of the asparagine-linked oligosaccharide unit.

Authors:  M L Hayes; F J Castellino
Journal:  J Biol Chem       Date:  1979-09-25       Impact factor: 5.157

6.  Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin.

Authors:  H Lilja; A Christensson; U Dahlén; M T Matikainen; O Nilsson; K Pettersson; T Lövgren
Journal:  Clin Chem       Date:  1991-09       Impact factor: 8.327

7.  Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3).

Authors:  H R Lijnen; F Ugwu; A Bini; D Collen
Journal:  Biochemistry       Date:  1998-04-07       Impact factor: 3.162

8.  Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors.

Authors:  A Christensson; C B Laurell; H Lilja
Journal:  Eur J Biochem       Date:  1990-12-27

9.  Isolation and characterization of microplasminogen. A low molecular weight form of plasminogen.

Authors:  G Y Shi; H L Wu
Journal:  J Biol Chem       Date:  1988-11-15       Impact factor: 5.157

10.  Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.

Authors:  M S O'Reilly; L Holmgren; Y Shing; C Chen; R A Rosenthal; M Moses; W S Lane; Y Cao; E H Sage; J Folkman
Journal:  Cell       Date:  1994-10-21       Impact factor: 41.582

View more
  19 in total

Review 1.  New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family.

Authors:  Nashmil Emami; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2007-09-15       Impact factor: 6.603

2.  No association between polymorphism in the vascular endothelial growth factor gene at position -460 and sporadic prostate cancer in the Turkish population.

Authors:  Ilke H Onen; Ece Konac; Muzaffer Eroglu; Cagri Guneri; Hasan Biri; Abdullah Ekmekci
Journal:  Mol Biol Rep       Date:  2007-01-11       Impact factor: 2.316

3.  Enzymatic activity of free-prostate-specific antigen (f-PSA) is not required for some of its physiological activities.

Authors:  Kailash C Chadha; Bindukumar B Nair; Srikant Chakravarthi; Rita Zhou; Alejandro Godoy; James L Mohler; Ravikumar Aalinkeel; Stanley A Schwartz; Gary J Smith
Journal:  Prostate       Date:  2011-03-28       Impact factor: 4.104

4.  Differential distribution of soluble and complexed forms of prostate-specific antigen in cyst fluids of women with gross cystic breast disease.

Authors:  M Malatesta; F Mannello; M Sebastiani; G Gazzanelli
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

5.  Engineering of human coagulation factor x variants activated by prostate-specific antigen.

Authors:  Tina Völkel; Hans-Heinrich Heidtmann; Rolf Müller; Roland E Kontermann
Journal:  Mol Biotechnol       Date:  2005-01       Impact factor: 2.695

Review 6.  The role of angiogenesis in prostate and other urologic cancers: a review.

Authors:  J I Izawa; C P Dinney
Journal:  CMAJ       Date:  2001-03-06       Impact factor: 8.262

7.  Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer.

Authors:  Jehana James; Daryl J Murry; Anthony M Treston; Anna Maria Storniolo; George W Sledge; Carolyn Sidor; Kathy D Miller
Journal:  Invest New Drugs       Date:  2006-09-13       Impact factor: 3.850

8.  TRP channels in prostate cancer: the good, the bad and the ugly?

Authors:  Dimitra Gkika; Natalia Prevarskaya
Journal:  Asian J Androl       Date:  2011-05-30       Impact factor: 3.285

Review 9.  Functional intersection of the kallikrein-related peptidases (KLKs) and thrombostasis axis.

Authors:  Michael Blaber; Hyesook Yoon; Maria A Juliano; Isobel A Scarisbrick; Sachiko I Blaber
Journal:  Biol Chem       Date:  2010-04       Impact factor: 3.915

10.  Angiogenic and antiangiogenic balance regulates concomitant antitumoral resistance.

Authors:  O Graciela Scharovsky; M Mercedes Binda; Viviana R Rozados; Sunita Bhagat; Michael L Cher; R Daniel Bonfil
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.